Autolus Therapeutics plc ( AUTL) - Stock Earnings
AUTL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026 BeforeMarket | -0.15 / — | — | 45.7 million / — | — |
AUTL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -90.2 million USD | 24.3 million USD |
| 2026Q1 | -71.6 million USD | 26.2 million USD |
| 2026Q2 | -39.1 million USD | 45.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
AUTL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -208.4 million USD | 1.7 million USD |
| 2024 | -220.7 million USD | 10.1 million USD |
| 2025 | -288.2 million USD | 75.6 million USD |
| 2026 Est. | — | — |
AUTL
Price: $2.15
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 412700
Market Capitalization: 590.8 million